 |
 |
 |
 |
 |
 |
 |
 |
|
|
| |
|
|
| |
NCCN Clinical Practice Guidelines in Oncology™
Each individual NCCN Guideline is posted with its latest update date and version number. NCCN Clinical Practice Guidelines in Oncology™ ©2007/2008 National Comprehensive Cancer Network. All rights reserved.
Guidelines for Treatment of Cancer by Site
- Acute Myeloid Leukemia
- Bladder Cancer
- Bladder Cancer
- Upper Tract Tumors
- Urothelial Carcinoma of the Prostate
- Bone Cancer
- Chondrosarcoma
- Ewing’s Sarcoma
- Osteosarcoma
-
Breast Cancer
- Noninvasive
- Invasive
- Phyllodes Tumor
- Paget's Disease
- Breast Cancer During Pregnancy
- Central Nervous System Cancers
- Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma
- Adult Intracranial Ependymoma
- Anaplastic Astrocytoma/Anaplastic Oligodendroglioma/Glioblastoma Multiforme
- Limited (1-3) Metastatic Lesions
- Multiple (>3) Metastatic Lesions
- Carcinomatous Lymphomatous Meningitis
- Nonimmunosuppressed Primary CNS Lymphoma
- Metastatic Spine Tumors
- Principles of Brain Tumor Therapy
- Cervical Cancer
- Chronic Myelogenous Leukemia
- Colon/Rectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Head and Neck Cancers
- Ethmoid Sinus Tumors
- Maxillary Sinus Tumors
- Salivary Gland Tumors
- Cancer of the Lip
- Cancer of the Oral Cavity
- Cancer of the Oropharynx
- Cancer of the Hypopharynx
- Occult Primary
- Cancer of the Glottic Larynx
- Cancer of the Supraglottic Larynx
- Cancer of the Nasopharynx
- Advanced Head and Neck Cancer
- Hepatobiliary Cancers
- Hepatocellular Carcinoma
- Gallbladder Cancer
- Intrahepatic Cholangiocarcinoma
- Extrahepatic Cholangiocarcinoma
- Hodgkin Disease/Lymphoma
- Kidney Cancer
- Melanoma
|
|
Guidelines for Detection, Prevention, & Risk Reduction
Guidelines for Supportive Care
Disclaimer
These guidelines are a statement of consensus of the authors regarding
their views of currently accepted approaches to treatment. Any clinician
seeking to apply or consult these guidelines is expected to use
independent medical judgment in the context of individual clinical
circumstances to determine any patient’s care or treatment. The
National Comprehensive Cancer Network makes no representations or
warranties of any kind regarding their content, use or application
and disclaims any responsibility for their application or use in
any way. These guidelines are copyrighted by National Comprehensive
Cancer Network. All rights reserved. These guidelines and the illustrations
herein may not be reproduced in any form without the express written
permission of NCCN. ©2007/2008.
Permission Requests
Please go to our Permission Request Section to submit a request.
Clinical Trials
The NCCN believes that the best management for any cancer patient
is in a clinical trial. Participation in clinical trials is especially
encouraged.
All recommendations are Category 2A unless otherwise specified.
See NCCN Categories of Evidence and Consensus.
Find a clinical trial at an NCCN Member Institution
Help with Viewing the NCCN Guidelines
Please maximize your browser window to view these guidelines. Please
note that there may be a delay of several seconds to a minute or
more, depending on the speed of your connection, as the PDFs download
into your browser window.
|
|
|
|
|